These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
3. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour. Koshikawa N; Kitamura M; Kobayashi M; Cools AR Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293 [TBL] [Abstract][Full Text] [Related]
4. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT. Mattingly BA; Himmler C; Bonta T; Rice LL Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes. GarcĂa-Sanz A; Badia A; Clos MV Synapse; 2001 Apr; 40(1):65-73. PubMed ID: 11170223 [TBL] [Abstract][Full Text] [Related]
6. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements. Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292 [TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296 [TBL] [Abstract][Full Text] [Related]
8. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Booth RG; Baldessarini RJ; Marsh E; Owens CE Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086 [TBL] [Abstract][Full Text] [Related]
9. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452 [TBL] [Abstract][Full Text] [Related]
13. Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride. Levant B; Garimelli B; Shafer RA; Merchant KM Neuropsychopharmacology; 1999 Aug; 21(2):304-11. PubMed ID: 10432478 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Devoto P; Collu M; Muntoni AL; Pistis M; Serra G; Gessa GL; Diana M Synapse; 1995 Jun; 20(2):153-5. PubMed ID: 7570345 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. Roberts C; Cummins R; Gnoffo Z; Kew JN Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride. Booze RM; Wallace DR Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338 [TBL] [Abstract][Full Text] [Related]
18. D2 and D1 dopaminergic activity of 7-OH-DPAT. Sethy VH; Ellerbrock BR; Fici GJ; Wu H Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246 [TBL] [Abstract][Full Text] [Related]
19. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Depoortere R; Perrault G; Sanger DJ Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044 [TBL] [Abstract][Full Text] [Related]
20. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT. Cook CD; Rodefer JS; Picker MJ Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]